As of June 21, 2025, Poniard Pharmaceuticals Inc (PARD) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Poniard Pharmaceuticals Inc's Forward P/E to Peers
To better understand Poniard Pharmaceuticals Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Poniard Pharmaceuticals Inc (PARD) | - |
| Intec Pharma Ltd (NTEC) | 1.78 |
Compared to its competitors, Poniard Pharmaceuticals Inc's Forward P/E is difficult to compare due to insufficient data.